Clinical Trials in Italy / NCT07275190
Recruiting
Not applicable
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
NCT07275190 · tracked via the Priya Life Science Italy tracker
Condition(s) studied
EGPA - Eosinophilic Granulomatosis With PolyangiitisHES - Hypereosinophilic Syndrome
Investigational drug(s) / intervention(s)
Blood draw for the laboratory assessment
Blood draw for the laboratory assessment: Blood draw for the laboratory assessment
Study summary
The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome, which will then be analyzed using artificial intelligence techniques with the aim of identifying characteristics that differentiate the two diseases and can predict the response to the treatment plan.
Eligibility
Inclusion Criteria:
1. 18 years of age or over
2. A diagnosis of EGPA or HES
3. Willing and able to give informed written consent, or willing to give permission for a nominated friend or relative to provide written informed assent if they are unable to do so because of physical disabilities
Exclusion Criteria:
1. Lack of a confirmed diagnosis of EGPA or HES.
2. Other causes of eosinophilia
Primary outcome measure(s)
- characteristics that are different between HES and EGPA — 18months
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fondazione IRCCS Policlinico San Matteo, SC Reumatologia | Pavia | Italy | Recruiting |
More Fondazione IRCCS Policlinico San Matteo di Pavia trials in Italy
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07275190 on ClinicalTrials.gov ↗ ← All trials in Italy